where is the scheduled release for feasibility studies of both the Breast Cancer and Ovarian Cancer detection? it was clearly presented that these reports will be released by Q1 2022, which is today.
- Forums
- ASX - By Stock
- IIQ
- Ann: Update on Legal Proceedings and BARD1 Autoantibody Program
Ann: Update on Legal Proceedings and BARD1 Autoantibody Program, page-31
-
- There are more pages in this discussion • 26 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add IIQ (ASX) to my watchlist
|
|||||
Last
59.5¢ |
Change
0.035(6.25%) |
Mkt cap ! $65.61M |
Open | High | Low | Value | Volume |
56.0¢ | 59.5¢ | 56.0¢ | $20.62K | 36.04K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 446 | 56.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
60.0¢ | 30002 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 446 | 0.560 |
4 | 19206 | 0.555 |
5 | 37050 | 0.550 |
1 | 10000 | 0.545 |
1 | 5550 | 0.540 |
Price($) | Vol. | No. |
---|---|---|
0.600 | 30002 | 3 |
0.620 | 11837 | 1 |
0.640 | 16800 | 1 |
0.650 | 20000 | 1 |
0.655 | 10248 | 3 |
Last trade - 15.57pm 23/08/2024 (20 minute delay) ? |
Featured News
IIQ (ASX) Chart |
The Watchlist
SER
STRATEGIC ENERGY RESOURCES LIMITED
David DeTata, Managing Director
David DeTata
Managing Director
SPONSORED BY The Market Online